ANA positivity trended towards increased risk, with 18% (19/103) of ANA positive patients compared to 11% (35/311) of ANA negative patients developing uveitis, however, this was not statistically significant (RR 1.64, CI 0.98–2.74, p = 0.06) (Fig. 3). The gene discussed is BTG3; the disease is uveitis.